 |
 |
 |
Company Information |
|
|
DiaSorin S.p.A Product Pipeline Analysis
Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 25
ISBN Number not applicable
Product Code GMD612
|
|
|
Summary
This report is an insightful source for data, analysis and strategic insights into a DiaSorin S.p.A's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reason to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
|
Content
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - In Vitro Diagnostics
- 3 DiaSorin S.p.A Pipeline Products
- 3.1 DiaSorin S.p.A Product Pipeline Analysis
- 3.1.1 DiaSorin S.p.A Pipeline Products By Equipment Type
- 3.1.2 DiaSorin S.p.A Pipeline Products By Development Stage
- 3.1.3 DiaSorin S.p.A Pipeline Products By Therapy Area
- 3.2 LIAISON 25-OH Vitamin D TOTAL assay-Automated
- 3.2.1 Product Description
- 3.2.2 Product Status
- 3.3 LIASION Osteocalcin
- 3.3.1 Product Description
- 3.3.2 Product Status
- 3.4 New version of LIASION testosterone
- 3.4.1 Product Description
- 3.4.2 Product Status
- 4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
- 5 History
- 6 Competitors
- 7 Key Employees
- 8 Company Statement
- 9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
- 10 Recent Developments
- 10.1 Financial Announcements
- 10.1.1 Feb 29, 2008: AOSL Declares 2007 Preliminary Results
- 10.1.2 Apr 01, 2007: AOSL Declares 2006 Results
- 11 Appendix
- 11.1 Methodology
- 11.1.1 Coverage
- 11.1.2 Secondary Research
- 11.1.3 Primary Research
- 11.1.4 Expert Panel Validation
- 11.2 Contact Us
- 11.3 About Global Markets Direct
- 11.4 Disclaimer
- List of Tables
- Table 1: DiaSorin S.p.A,Key Facts
- Table 2: DiaSorin S.p.A Pipeline Products by Equipment Type
- Table 3: DiaSorin S.p.A Pipeline Products By Development Stage
- Table 4: DiaSorin S.p.A Pipeline Products By Therapy Area
- Table 5: DiaSorin S.p.A, Key Employees,
- Table 6: DiaSorin S.p.A, Other Locations
- Table 7: DiaSorin S.p.A, Subsidiaries
- List of Figures
- Figure 1: Global Markets Direct Methodology
|
|
|